HMPL-523, a novel SYK Inhibitor, showed anti-tumor activities in vitro and in vivo (ASH 2016)

 HMPL-523_Preclinical_ASH_2016_thumbASH 2016: Syk Inhibitor HMPL-523 Anti-tumor Activity in vitro and in vivo

HMPL-523, a Novel SYK Inhibitor, Showed Anti-tumor Activities in Vitro and in Vivo

Na Yang, Wei Deng, Qiaoling Sun, Junqing Liang, Linfang Wang, Shiming Fan, Renxiang Tang, Ying Yu, Junen Sun, Feng Zhou, Guangxiu Dai, Yongxin Ren, Weiguo Qing and Weiguo Su


Event: American Society of Hematology Annual Meeting

Title: HMPL-523, a Novel SYK Inhibitor, Showed Anti-Tumor Activities in Vitro and in Vivo

Abstract number: 3970

Session: 605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Date & Time: Monday, December 5, 2016, 6:00PM – 8:00PM (PST)

Download Poster (PDF)